好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Computational Analysis of Subarachnoid Hemorrhage Pattern Can Indicate the Presence of Aneurysm
Neuro Trauma and Critical Care
P7 - Poster Session 7 (8:00 AM-9:00 AM)
1-003

To design a predictive model, based on radiographic measurements of admission non-contrasted head computerized tomography (NCHCT), to differentiate perimesencephalic subarachnoid hemorrhage (pmSAH) from aneurysmal causes.

pmSAH is a predominantly benign pattern of subarachnoid hemorrhage. However, in a minority of pmSAH, a posterior circulation aneurysm is causative. Out of concern for missing an aneurysm, many institutions pursue exhaustive imaging, leading to longer ICU length of stay and a considerable resource burden. Previous efforts to predict the presence of aneurysm relied on qualitative visual inspection of hemorrhage patterns. 

We retrospectively reviewed consecutive patients admitted for suspected aneurysmal SAH (aSAH) to an academic center. Patients with a final diagnosis of pmSAH or posterior circulation aSAH were included. Using NCHCT, thickness (continuous variable) and location of blood in basal cisterns and Sylvian fissures (categorical variables) were compared between groups. Using the statistically significant features, we created a scoring system. Receiver operating characteristics (ROC) were used to measure accuracy of this model in predicting aneurysmal etiology. 

Of 420 SAH cases, we identified 49 with pmSAH and 46 with posterior circulation aSAH. Mean age was 53 years (SD 11) and 46 patients (48%) were female. Blood thickness measurements in the crural and ambient cisterns, interhemispheric and Sylvian fissures, and degree of extension into the Sylvian fissure were all statistically significant (p= <0.001, <0.001, <0.001, <0.001, and <0.001, respectively). Using these significant figures, we developed a 10-point scoring model to predict aneurysmal causes with high accuracy (area under the curve [AUC] 0.99; 95% CI 0.98-1.00; odds ratio per point increase: 10; 95% CI 2.18-46.4).

If externally validated, our predictive model may assist clinicians in the risk-stratification of patients presenting with pmSAH. This model could minimize protracted admissions to intensive care units and reduce healthcare resource utilization and costs.

Authors/Disclosures
Daniel Mandel, MD
PRESENTER
Dr. Mandel has nothing to disclose.
Kelly Pan Ms. Pan has nothing to disclose.
Scott Moody No disclosure on file
Bradford B. Thompson, MD (St. Elizabeth’s Medical Center) Dr. Thompson has nothing to disclose.
Linda C. Wendell, MD, FAAN (Mount Auburn Hospital) Dr. Wendell has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. An immediate family member of Dr. Wendell has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. Dr. Wendell has stock in Apple. An immediate family member of Dr. Wendell has stock in Apple.
Jesse Menville Ms. Menville has nothing to disclose.
Karen L. Furie, MD (RIH/Alpert Medical School of Brown Univ) The institution of Dr. Furie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen/BMS. Dr. Furie has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ/JNNP. The institution of Dr. Furie has received research support from NINDS.
Ali Mahta, MD (Brown University) Dr. Mahta has received research support from Brown University Health.